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Abstract  
BACKGROUND: Infections caused by Hepatitis B are one of the world health’s most serious problems. According 
to assessments, nearly 500,000 to 1.2 million people die each year due to chronic hepatitis, cirrhosis of the liver 
and hepatocellular carcinoma. Hepatitis B is one of the diseases which can be transferred through blood and its 
products. Clinical importance of genotypes of hepatitis B virus and their relations with mutations are well known. 
AIM: Since epidemiological data resulting from determining genotypes and sub-genotypes of hepatitis B can help 
a lot in defining a vaccination plan, antiretroviral therapy, detection and prevention of diseases, genotypes of this 
virus in hepatitis B patients were evaluated in West Azarbaijan province. 
MATERIALS AND METHODS: In this cross-sectional study, serum samples of 100 hepatitis B patients (70 
male/30 female)  were taken randomly from Urmia University of Medical Sciences (UMSU) referrals, Urmia, Iran; 
and were tested positive for the presence of surface antigens of hepatitis B virus (HBsAg) using ELISA method. In 
the first method, after extracting the DNA of the virus, sequencing of S genes was carried out using Sanger 
method, and the sequences were aligned and edited using Bioedit software. In the next step, phylogenic analysis 
of the sequences was done in comparison with the reference sequences which were extracted from a gene bank, 
utilising Neighbour-joining assay method with CLUSTRAL W software. To ensure genotyping accuracy, the 
samples were tested once more, using Nested PCR method.  
RESULTS: The results were consistent with the sequence method and the dominant genotype in patients 
suffering hepatitis was type D. In other words, Iranian’s HBV genotypic types are homogeneous and in close 
coordination with each other.  
CONCLUSIONS: The results reveal that D genotype is the main genotype of HBV in West Azarbayjan province, 
northwest Iran. Presence of this genotype was in conformity conformed withto the low rate of acute liver diseases 
caused by hepatitis B chronic infection, cirrhosis of the liver and hepatocellular carcinoma. 
 
 
 
 
 
Introduction 
 
Hepatitis B is one of the global health 
problems. According to the statistics of world World 
health Health organizationOrganization, it’s it is the 
third most prevailing infectious and contagious 
disease after Tuberculosis and Malaria and is the fifth 
cause of death from infectious disease in the world. 
There are 2 billion people infected with hepatitis B and 
more than 350 million people (5% of total population 
of the world) are reported to be chronic carriers of 
hepatitis B [1]. 
There are four million new clinical hepatitis B 
patients each year and one million of hepatitis B 
carriers die from active chronic hepatitis and cirrhosis 
of liver annually. Hepatitis B virus (HBV) is one the 
causes of acute and chronic hepatitis and liver cancer 
in Asia and especially in China, Taiwan, Africa and 
South America [2]. Hepatitis B genome is a double-
stranded DNA which is not completely circular and 
has has 3200 base pairs. Hepatitis B genome have 
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four open reading frames called S, C, P and X. Using 
advanced evolutionary analysis and based on HBV 
similarity of similarity HBV between full genome of 
virus, 8 genotypes are identified which are based on 
more than 8% complete A-H genome sequence 
variation [3]. 
DNA of the virus consists of 4 groups of genes: S 
gene (surface shield of antigen or s protein codes 
HBsAg), C gene (Hepatitis B Nucleocapsid proteins, 
viral capsid or nuclear antigen or HbcAg and codes e 
antigen), P gene (DNA polymerase) and X gene 
(which codes transactivating protein) which increases 
hepatitis B virus duplication. P gene covers almost 
180 percent of genome of virus, fully covers S gene 
and a part of it overlaps with C and X genes. In 
addition, pre-core and core promotore shares are a 
significant area of genome sequence with X gene [3, 
4]. 
Studies show that clinical outbreak, prognosis 
and response to treatment of the disease depends on 
genotype of virus. Hepatitis B genotype has a certain 
type of geographical distribution. In North America, 
Northern Europe, India and Africa, A genotype, in 
Asia, B and C genotypes, in Middle East, 
Mediterranean area and India, D genotype, in west 
and south Africa, E genotype, in Southern and central 
America, F genotype and in America and Europe, G 
and H genotype are dominant [5-8]. 
All genotypes of HBV will cause liver disease, 
but their clinical signs are different. C genotype is 
prevalent in cirrhotic patients. A genotype often lead 
to chronicity of illness and D genotype is typically 
observed in patients who are intravenous drug users. 
But some researches demonstrate that B genotype 
was more frequently observed in Taiwan youngsters 
who didn’t have cirrhosis of liver rather than D 
genotype. D genotype was also less connected to 
acute liver diseases and cancer compared to A 
genotype [5, 9]. 
Studies conducted on a limited number of 
patients show that chronicity ratio in individuals with A 
and D genotypes is higher than B and C genotypes. 
The ratio of development of persistent HBV infection 
after severing hepatitis B infection is higher in A 
patients rather than B and C genotype patients. They 
also reported a higher chronicity after HBV infection in 
D genotype patients [10]. 
The only host to HBV is a human being, and 
chronic carriers are the only source of virus in nature. 
It is estimated that more than 35% of Iranians had 
contact with HBV and 3% are chronic carriers which 
1.7% of them are in Fars province and more than 5% 
are in Sistan-Va-Balouchestan province. In a study 
carried out on 250,000 of healthy volunteers of blood 
donation, 3.6% of men and 1.6% of women were 
carriers of HBsAg [11, 12].   
Anti-HBV antibody was identified in 37% of 
this population. Thus, it seems that 8% of Iranians 
which are suffering hepatitis B will be chronic carriers. 
Studies conducted in the last decade demonstrate 
that in patients with cirrhosis of the liver, 70% to 84% 
have evidence of contacting HBV and 51% to 56% are 
vectors. Also, in Iranian patients with hepatocellular 
carcinoma, HBsAg was positive in 72% of virus 
encounters, and carriage rate is reported to be 46% 
[2, 11, 12].  
Since epidemiologic data resulting from 
determining genotypes and sub-genotypes of hepatitis 
B virus help a lot in defining a vaccination program, 
antiretroviral therapy, diagnosing and prevention of 
the disease, this research was conducted to study 
hepatitis B virus genotypes in West Azarbaijan, 
northwest Iran; province which was not studied 
previously. 
 
 
Material and Methods 
 
Cross sectional study were carried out on 100 
patients (70 male/30 female) in 2014-2015 year. 
hepatitis B patients were chosen randomly from 
UMSU hospitals. Five milliliters of blood were 
collected from each patient. After 15 minutes 
incubation at room temperature samples were 
centrifuged at 1000 g. Serum were separated and 
kept at -40 degree centigrade until the experiments 
were preformed. Sample wereSamples were assayed 
for presence of HBsAg by using the ELISA method 
(PishTaz Teb, Tehran, Iran). 
In order to determine  hepatitis B 
genotypeing, positive 100 serum samples which are 
positive in the ELISA method, DNA purification carried 
out by using Nucleic acid extract kit(QIA amp DNA 
miniKit, Germany) which was based on affinity 
chromatography utilizing silica columns, and DNA 
extracted samples divided in two parts.   
 
HBV genotyping by sequencing 
The first part of the extracted DNA from 
hepatitis B virus was sent to South Korea with the aid 
of Iran Pasteur Institute. Sequencing of S genes were 
carried out using Sanger method, and the sequences 
were aligned and edited using Bioedit software. In the 
next step, phylogenic analysis of the sequences were 
done in comparison with the reference sequences 
which were extracted from a gene bank, utilizing 
Neighbor joining assay method with CLUSTRAL W 
software.   
 
NESTED PCR method 
Also nested Nested PCR method was carried 
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out by hepatitis B virus kit (Genekam Biotechnology 
AG, Germany) by second part of extracted DNA, 
extracted materials as described before.  
Primers were used a are shown in table 1, 
[13]. Electrophoresis were carried out by PCR 
products in 60 volts in TAE buffer (2 M Tris-Acetate, 
0.05 M EDTA-K2) and 2% agarose gel containing 
syber Syber green dye. DNA bands in compare with 
molecular size marker with maximum 500 bp in visible 
zero UV rays to the gel.   
Table 1: Designed primers for identification of hepatitis B 
genes using nested PCR method 
Sequence a (position, specificity, and polarity) Primer 
 PCR  first 
5’-TCA CCA TAT TCT TGG GAA CAA GA-3’ (nt 2823-2845, 
universal, sense) 
5’-CGA ACC ACT GAA CAA ATG GC-3’ (nt 685-704, universal, 
antisense) 
P1b 
S1-2 
 PCR 2nd 
Mix A 
5’-GGC TCM AGT TCM GGA ACA GT-3’ (nt 67-86 types A to E 
specific, sense) 
5’-CTC GCG GAG ATT GAC GAG ATG T-3’ (nt 113-134, type A 
specific, antisense) 
5’-CAG CCT AGG AAT CCT GAT GTT G-3’ (nt 165-186, type C 
specific, antisense) 
B2 
BA1R 
BC1R 
 
5’-GCC AAC AAG GTA GGA GCT-3’ (not 2979-2996, type D 
specific, sense) 
5’-CAC CAG AAA TCC AGA TTG GGA CCA –3’ (nt 2955-2978, 
type E specific, sense) 
5’-GYT ACG GTC CAG GGT TAC CA-3’ (nt 3032-3051, type F 
specific, sense) 
5’-GGA GGC GGA TYT GCT GGC AA-3’ (nt 3078-3097, types D 
to F specific, antisense) 
Mix B 
BD1 
BE1 
BF1 
B2R 
 
 
Results 
 
After genotyping HBV with S gene sequence 
utilizing Sanger sequencing method, all samples 
shows hepatitis B virus D genotypes. 
Also carrying out Nested PCR by nested 
method genotyping and compare with DNA molecular 
size with maximum of 500 bp in agarose gel all 
samples were revealed in 119 bp witch which is the 
sign of type D genotype.  
There are no other genotypes were observed 
in our experiments, figure Figure 1. 
 
Figure 1: According to the marker, all bands belong to 119 bp and 
identified D genotype which for type A in 68 bp, for type B in 281 
bp, for type C in 122 bp, for type E in 167 bp and for type F in 97 bp 
no bands were visible 
Discussion 
 
Hepatitis B chronic infection is a widespread 
disease which infected more than 5% of the world’s 
population and is one of the biggest health problems 
of Iran and the world. The prevalence of hepatitis B is 
endemic in the world. 90% of the world’s population 
are living in areas with high prevalence of 8% of 
positive HBsAg or with medium prevalence of 82-28% 
of HBsAg [11]. Iran is located in the middle eastMiddle 
East and according to Center for Disease Control, 
havehas medium prevalence of the infection. 
Prevalence of positive HBsAg in 1357 1982 in Iran 
was reported to be 2.5%-7.2% [12, 14]. Even though 
hepatitis B has low prevalence in Bahrain and Kuwait, 
medium in Iran, USA and United Arab Emirates and 
high in Oman, Palestine, Yemen and Sweden, 
positive HBsAg prevalence in ordinary people was 
reportedly 1.7% and in blood donors was reported to 
be 0.5% [12, 15, 16]. 
This study was first carried out in West 
Azarbayjan province, north west Iran; in order to 
determine hepatitis B genotypes among hepatitis B 
patients utilizing sequencing method and Nested PCR 
method on polymerase gene of hepatitis B virus. In 
this method, blood samples of one hundred patients 
which were randomly chosen and tested positive for 
the presence of surface antigens of Hepatitis hepatitis 
B virus (HBsAg) using ELISA method and HBV with 
PCR method, were taken and the experiment were 
carried out on these samples. 
Studies show that there is a meaningful 
relation between HBV genotypes with illness severity, 
Cirrhosis cirrhosis of the liver and Hepatocellular 
hepatocellular carcinoma and response to treatment 
[17]. Recent data suggests that patients with C 
genotype would probably have a greater chance of 
being subject to severe liver diseases while those who 
have B genotypes have a greater chance of 
hepatocellular carcinoma [18, 19]. According to the 
latest studies, 8%-20% of individuals with hepatitis B 
are its carriers and prevalence of hepatitis B in Middle 
East and Iran is reported to be 2%-7% [12, 20] 
One of the discussions made in hepatitis B 
researches, is the geographical distribution of this 
virus which has different patterns in different regions 
of the world. D genotype is dominant in Middle East 
and Mediterranean countries which are confirmed 
through multiple studies [21]. 
In a research carried out by Eftekhari et al., in 
2010 on positive HbsAg patients, GAP-PCR method 
was utilized in order to determine the genotype. 
Results showed that in 60% of the individuals, HBc-Ab 
antibody was tested positive and the dominant 
genotype in these patients was type D [22]. 
In a similar study by Goodarzi et al. in 2007 
[23] which was conducted to determine the genotype 
Basic Science 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
878                                                                                                                                                                                                                       http://www.mjms.mk/ 
http://www.id-press.eu/mjms/ 
 
of HBV in Iran, S and C genes of the virus were 
studied using sequencing and phylogenic analysis 
method in preS area. The results of their investigation 
demonstrated that in HCC patients all extracted 
genotypes were typed D. Albeit in positive HBsAg 
patients, utilising reverse hybridisation method 
demonstrated that in 86% of chronic hepatitis patients, 
10% of Cirrhosis patients and 2.7% of carriers, the 
only identified genotype is type D [24]. 
In researches done in different areas of Iran, 
the dominant genotype is D genotype, but some 
studies reported B and C genotypes [11]. The 
research was conducted by Karimi et al. in 2013 [25] 
on serums of 116 patients with the positive surface 
antigen of HBV. The results showed that 19.8% were 
positive concerning hepatitis B nucleic acid and the 
dominant genotype in these individuals was D 
genotype in 73.9% of the cases. 26.1% of patients 
were found to have C genotype. 
In a similar study in India, A and D genotypes 
were dominant. According to this study, D, A and C 
genotypes were observed in 57.3%, 18% and 11.5% 
of patients with chronic HBV infection respectively, 
respectively. D genotype was more prevalent in 
chronic liver patients in New Delhi [26]. In north east 
areas genotype C is dominant in high risk individuals 
and is more connected with liver disease progression 
[27]. Other researches of the same kind performed in 
middle easternMiddle Eastern countries like Saudi 
Arabia, lead to similar results which shows D 
genotype in more than 80% of hepatitis B (HBV) 
patients [28]. 
In other areas such as Mediterranean area, 
Middle East and South Eastern Asia, D genotype is 
prevalent and similar results in Turkey demonstrated 
that all 44 patients which were tested, had D 
genotypes [29]. 
In this study, D genotype was found to be 
dominant in infected patients. In other words, HBV 
genotypic types are in close connection with each 
other and are homogeneous and there is no 
connection between the genotype of virus and the 
investigated population (epidemiologically). This fully 
complies with the results previously obtained in Iran, 
Middle East, Afghanistan, Central Asia, Turkey, Egypt, 
New Delhi and British Colombia [30]. 
Despite all the investigations carried out in 
Iran, data on HBV genotypes are very limited because 
of the fact that in some cases, differences in 
genotypes can be found within a country and thus the 
necessity of regional studies in order to determine 
HBV genotypes in West Azarbayjan province is 
justified [31]. 
The results of this study demonstrate that the 
dominant genotype in West Azarbayjan is similar to 
other regions of Iran. D genotype is the dominant 
genotype in Iran and other Middle Eastern countries. 
In a research conducted by Alavian et al., the only 
genotype found in HBV patients in Iran was type D [9]. 
Utilizing different methods in the studies lead to 
similar results. Therefore it can be conducted that the 
dominant genotype in Iran was type D. Analogous 
results despite different methods utilized, are an 
evidence of gene dominancy [32]. 
In a study performed by Yalchin et al., liver 
enzymes level were investigated and were found to be 
normal. In this research, ALT and AST liver enzymes 
were measured and were found to be normal. It 
seems like enzyme variation doesn’t have a 
meaningful connection with HBV virus and does not 
change significantly [29] and was in conformity with 
the present research. 
 In conclusion, the results show that D 
genotype is the main genotype of HBV in West 
Azarbayjan province. This study opens the door to 
perform further studies such as understanding the 
effects of antiviral drugs on HBV infected patients. 
Researches on subgenotypes of HBV and its 
serotypes can be conducted, and the original and 
effective anti-viral drugs may be used to treat infected 
patients.  
These results can be utilised in the 
immunological and genetic diagnosis of HBV to make 
hepatitis B diagnostic kits and quality control panels 
for evaluation of diagnostic methods of the virus. 
Genotyping can be done in bigger cities of West 
Azarbayjan and may be compared to the present 
results.  
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